InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Hawkins Richard J, Chairman & CEO. Officer active across 4 companies, notably Savara Inc. In total, 5 reports have been recorded. The latest transaction was disclosed on 1 April 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
€12,2211,466 shares@ €8.336123.3% of flow
Common Stock
SEC:0001126234-22-000032:0·
€40,1534,500 shares@ €8.9228100.0% of flow
Common Stock
SEC:0001126234-22-000007·
€40,1534,500 shares@ €8.922876.7% of flow
Common Stock
SEC:0001126234-22-000007:0·
€354728 shares@ €0.48620.0000% mcap100.0% of flow
Common Stock
SEC:0001209191-21-069582·
€354728 shares@ €0.48620.0000% mcap100.0% of flow
Common Stock
SEC:0001209191-21-069582:0·
5 of 5 declarations
About Hawkins Richard J
Richard J. Hawkins is the Chief Executive Officer of Savara Inc. and Lumos Pharma, Inc. In these roles, he oversees the strategic and commercial operations of the companies, which specialize in developing innovative treatments. With extensive experience in the sector, he is committed to leading the companies towards innovation and sustainable growth. His leadership is essential for strengthening their market position.
